Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kara M Ruicci

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Facial Plastic Surgery & Aesthetic Medicine|June 24, 2021
Aesthetic Reconstruction of the Gauge Earlobe: Surgical Technique and Case SeriesKara M Ruicci, Corey C Moore
Clinical Lung Cancer|June 18, 2026
Off-Protocol Radiotherapy in Prospective Systemic Therapy Trials for Metastatic Non-Small Cell Lung CancerKara M Ruicci, George J Li, Andrew Warner, et al.
Oral Oncology|August 18, 2018
ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibitionKara M Ruicci, Nicole Pinto, Mohammed I Khan, et al.
Molecular Oncology|December 6, 2019
Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibitionKara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
International Journal of Cancer|November 24, 2018
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growthKara M Ruicci, Jalna Meens, Ren X Sun, et al.
Molecular Oncology|August 9, 2019
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibitionKara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 16, 2020
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinomaKara M Ruicci, Jalna Meens, Paul Plantinga, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|February 23, 2022
Introduction and expression of PIK3CA<sup>E545K</sup> in a papillary thyroid cancer BRAF<sup>V600E</sup> cell line leads to a dedifferentiated aggressive phenotypeNicole Pinto, Kara M Ruicci, Mohammed Imran Khan, et al.
Plos One|November 13, 2018
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line modelsNicole Pinto, Stephenie D Prokopec, Frederick Vizeacoumar, et al.
Oncotarget|June 15, 2018
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell linesFarhad Ghasemi, Morgan Black, Ren X Sun, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Facial Plastic Surgery & Aesthetic Medicine|June 24, 2021
Aesthetic Reconstruction of the Gauge Earlobe: Surgical Technique and Case SeriesKara M Ruicci, Corey C Moore
Clinical Lung Cancer|June 18, 2026
Off-Protocol Radiotherapy in Prospective Systemic Therapy Trials for Metastatic Non-Small Cell Lung CancerKara M Ruicci, George J Li, Andrew Warner, et al.
Oral Oncology|August 18, 2018
ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibitionKara M Ruicci, Nicole Pinto, Mohammed I Khan, et al.
Molecular Oncology|December 6, 2019
Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibitionKara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
International Journal of Cancer|November 24, 2018
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growthKara M Ruicci, Jalna Meens, Ren X Sun, et al.
Molecular Oncology|August 9, 2019
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibitionKara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 16, 2020
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinomaKara M Ruicci, Jalna Meens, Paul Plantinga, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|February 23, 2022
Introduction and expression of PIK3CA<sup>E545K</sup> in a papillary thyroid cancer BRAF<sup>V600E</sup> cell line leads to a dedifferentiated aggressive phenotypeNicole Pinto, Kara M Ruicci, Mohammed Imran Khan, et al.
Plos One|November 13, 2018
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line modelsNicole Pinto, Stephenie D Prokopec, Frederick Vizeacoumar, et al.
Oncotarget|June 15, 2018
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell linesFarhad Ghasemi, Morgan Black, Ren X Sun, et al.
Pageof 2